Anlotinib Combined With Dose-dense Temozolomide for the First Recurrent or Progressive Glioblastoma After STUPP Regimen
Clinical trial NCT04547855 · UNKNOWN
Trial details
- NCT number
- NCT04547855
- Sponsor
- Yonggao Mou
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-09-11
- Primary completion
- 2022-09-11
- Enrollment
- 54
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.